Amended Complaint Filed Over Ditropan
Both complaints accuse the makers and distributors of Ditropan XL of illegally trying to keep generic versions off the market by suing and entering into anti-competitive agreements with potential competitors.
But the new complaint contains some changes, including a second defendant, Ortho-McNeil Pharmaceuticals Inc.—the company that distributes Ditropan XL...
Already a subscriber? Click here to login